Acquisition

With 14% growth, strategic acquisitions, and major AI advancements, Real Chemistry is redefining healthcare commercialization on its 25th anniversary.

Forum Investment Group hires Ares vet Grant Turner in a strategic bid to scale its 1031 exchange platform and capture the booming tax-advantaged market.

A major contract with HawkEye 360 signals Europe's urgent push for sovereign defense, using commercial satellites to monitor invisible threats from space.

A $1.25B fund's purchase of a Lake Bluff community highlights institutional capital's growing appetite for the booming senior housing sector.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

After a strategic bankruptcy, the iconic Blackboard brand is back. Now debt-free and refocused, it's poised to challenge the EdTech market once again.

Virtus Investment Partners' deal for Keystone National Group signals a major push to bring asset-backed lending to the mainstream wealth channel.

The insurer posts historic earnings and a $2.9B dividend, showcasing growth beyond insurance into wealth management and strategic tech investments.

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.

The acquisition of PRL Associates marks another step in King Risk Partners' aggressive Northeast expansion, reflecting a broader trend of market consolidation.

After a major turnaround, Genetix Biotherapeutics announces its first profitable quarter and plans to double production of its high-stakes gene therapies.

French giant Efor deepens its North American footprint, acquiring CQV specialist DynamixE to target the complex cell and gene therapy manufacturing market.

Ag Growth International brings back its 23-year former CFO to the board, signaling a major push for operational excellence amid financial pressures.

NVIDIA invests billions in optics leader Coherent to secure the high-speed, US-made components needed to power the next generation of AI factories.

With its sixth deal of 2026, WhiteHawk expands its footprint in the Haynesville Shale, tying its fortunes to the booming but controversial U.S. LNG market.

OneSpan finalizes its acquisition of Build38, integrating AI-driven defenses to combat a new generation of sophisticated mobile and financial threats.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

In a deal highlighting intense focus on supply chain resilience, J.F. Lehman acquires critical forgings provider Forged Solutions Group from Arlington Capital.

With 175 million lenses implanted, Alcon solidifies its market leadership. Discover the technology giving patients unprecedented freedom from glasses.

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.